News About: Pharm. Industry
Samjin studying anti-cancer drug development, SJ-8002.
Samjin announced that SJ-8002, an anti-cancer drug of piperazine derivative, was successfully developed having an anti-cancer mode of actions by blocking the microtubule generation, angiogenesis and inducement of tumo...
Proprietors of pharmacy urged to promote OTC sales
Pharmaceutical business sources say that proprietors of pharmacy should brace for improving their management conditions via a variety of business diversification programs including activated OTC sales to help conserve...
NovoMix 30 Flexpen to be available in KoreaNovo Nordisk Korea announced on August 19 that NovoMix 30 Flexpen (reimbursable price: 11,706 won/3ml), the dual-release insulin analogue and pen system designed specifically fo...
|
Domestic pharmaceutical firms' R&D overseas projects seen intensifying
A number of domestic leading pharmaceutical firms are expected to increase their R&D investment in foreign countries, as the Korea Pharmaceutical Manufacturers Association and the Korea Health Industry Development Ins...
Sanofi to keep stronghold wholesale system.
Sanofi Korea announced that they would absorb the wholesale business from Zuellig to keep their own whole selling system called "a stronghold wholesale system".
Sanofi Korea said on Aug. 18 that their wholesale bu...
Dietary items emerging as most attractive health foods
Healthier dietary items are gaining big popularity in Korea, a recent Internet survey showed.
The on-line survey of 282 Netizens, which was conducted by Yakup Shinmoon (www.yakup.com) between July 19 to August 9,...
Green Cross Sang-A and PBM to merger.In the extraordinary shareholder's meeting on Aug. 17 Green Cross Sang-A decided the merger of Green Cross PBM, the revision of the article of incorporation to add a commodity b...
|
Advertisement campaigns centered around OTCs in first half
During the first six months, a number of leading pharmaceutical firms geared up its intensive public advertisement campaigns in an effort to jump-start OTC sales amid protracted business slump and plan to intensify th...
Pharmaceutical sales showing strong momentum despite sluggish economy
Amid depressed OTC demand and a slumping economy since the implementation of a system of separating drug dispensing from medical practice in 2000, sales by pharmaceutical firms have been gradually gaining momentum fro...
Norvasc and Amaryl generics on hot competition.
A competitive market entry of many patent expired products bursted into its flames in the market far earlier than expected.
Amrlodipine and Glipiramide generics successfully obtained the NHI reimbursement price app...
